• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.25% Nasdaq Up 0.65%

    Alcobra Ltd. (ADHD)

    -NasdaqGM
    5.12 Up 0.10(1.99%) May 27, 4:00PM EDT
    Prev Close:5.02
    Open:5.02
    Bid:N/A
    Ask:9.80 x 100
    1y Target Est:12.17
    Beta:1.21373
    Earnings Date:Jul 27 - Aug 3 (Est.)
    Day's Range:4.68 - 5.30
    52wk Range:3.15 - 9.50
    Volume:69,971
    Avg Vol (3m):108,823
    Market Cap:141.11M
    P/E (ttm):N/A
    EPS (ttm):-0.82
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ADHDUp 1.99%141.11M
    JNJUp 0.14%310.99B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-1.00
    Quarterly EPS Est (Jun-16) :-0.23
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of oral drug candidates. The company is primarily developing MDX (metadoxine), an onset/extended release formulation of the chemical pyridoxine pyroglutama... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback